supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs
Craig Koniver found many benefits of using BPC-157 in his clinic before it was removed by the FDA, confirming the above hypotheses that it is an anti-inflammatory and tissue healer
Our clinic provides a professional, welcoming, and confidential environment where you can feel comfortable discussing your goals
Men with asthenospermia have less than 40% sperm motility or less than 32% progressive motility
Ethanol Gastric Lesion Aggravated by Lung Injury in Rat
This is the first deep-dive post in the peptide series
